Open AccessLenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis
Author(s) -
Silvia Mangiacavalli,
Claudio Salvatore Cartia,
Mónica Galli,
Sara Pezzatti,
Angelo Belotti,
Francesca Fazio,
Roberto Mina,
Magda Marcatti,
Anna Maria Cafro,
Renato Zambello,
Laura París,
Gregorio Barilà,
Cecilia Olivares,
Alessandra Pompa,
Rita Mazza,
Francesca Farina,
Martina Soldarini,
Pietro Benvenuti,
Giuseppina Pagani,
Marco Palumbo,
Valeria Masoni,
Virginia Valeria Ferretti,
Catherine Klersy,
Luca Arcaini,
Maria Teresa Petrucci
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2022.281342
Subject(s) - carfilzomib , lenalidomide , medicine , tolerability , propensity score matching , regimen , multiple myeloma , oncology , randomized controlled trial , dexamethasone , adverse effect